Chevret Laurent, Durand Philippe, Lambert Jerome, Essouri Sandrine, Balu Laurent, Devictor Denis, Tissieres Pierre
1Pediatric Intensive Care and Neonatal Medicine, Paris South University Hospitals, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France. 2Department of Biostatistics, St. Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. 3School of Medicine, Paris South University, UPS 11, Le Kremlin-Bicêtre, France. 4Institute of Genetics and Microbiology, School of Sciences, Paris South University, Orsay, France.
Pediatr Crit Care Med. 2014 Sep;15(7):e300-5. doi: 10.1097/PCC.0000000000000172.
High-volume hemofiltration has shown beneficial effects in severe sepsis and multiple organ failure, improving hemodynamics and fluid balance. Recent studies suggest that acute liver failure shares many pathophysiologic similarities with sepsis. Therefore, we assessed the systemic effects of high-volume hemofiltration in children with acute liver failure.
Retrospective observational cohort study.
Twenty-two children.
Forty-two-bed multidisciplinary pediatric and neonatal ICUs in a tertiary university hospital.
We evaluated high-volume hemofiltration therapy as part of standard management of 22 children admitted in our unit for acute liver failure. Fifteen patients had fulminant hepatic failure, three had acute-on-chronic liver disease, and four had primary nonfunction. High-volume hemofiltration was initiated in patients requiring emergency liver transplantation and when hepatic encephalopathy grade higher than 2 and/or hemodynamic instability requiring vasopressors occurred. High-volume hemofiltration was defined by a flow of ultrafiltrate of more than 80 mL/kg/hr. Clinical and biological variables were assessed before and 24 and 48 hours after initiation of high-volume hemofiltration therapy.
High-volume hemofiltration was initiated with a median grade III of hepatic encephalopathy. The median flow of ultrafiltrate was 119 mL/kg/hr (range, 80-384). After 24 hours of high-volume hemofiltration treatment, we observed an increase in mean arterial pressure (p = 0.0002) and a decrease in serum creatinine (p = 0.0002). In half of the patients, the encephalopathy grade decreased. After 48 hours of treatment, mean arterial pressure (p = 0.0005), grade of hepatic encephalopathy (p = 0.04), and serum creatinine (p = 0.0002) improved. Overall mortality was 45.4% (n = 10). Emergency liver transplantation was performed in eight children. Five patients spontaneously recovered liver function.
High-volume hemofiltration therapy significantly improves hemodynamic stability and neurological status in children with acute liver failure awaiting for emergency liver transplantation.
高容量血液滤过已在严重脓毒症和多器官功能衰竭中显示出有益效果,可改善血流动力学和液体平衡。近期研究表明,急性肝衰竭与脓毒症在许多病理生理方面存在相似之处。因此,我们评估了高容量血液滤过对急性肝衰竭患儿的全身影响。
回顾性观察队列研究。
22名儿童。
一所三级大学医院中拥有42张床位的多学科儿科和新生儿重症监护病房。
我们将高容量血液滤过治疗作为本单位收治的22例急性肝衰竭患儿标准治疗的一部分进行评估。15例为暴发性肝衰竭,3例为慢性肝病急性发作,4例为原发性无功能。在需要紧急肝移植的患者以及出现肝性脑病分级高于2级和/或需要血管升压药治疗的血流动力学不稳定情况时,启动高容量血液滤过。高容量血液滤过定义为超滤流量超过80 mL/kg/小时。在启动高容量血液滤过治疗前以及治疗后24小时和48小时评估临床和生物学变量。
高容量血液滤过开始时肝性脑病的中位分级为III级。超滤的中位流量为119 mL/kg/小时(范围为80 - 384)。高容量血液滤过治疗24小时后,我们观察到平均动脉压升高(p = 0.0002)以及血清肌酐降低(p = 0.0002)。一半患者的肝性脑病分级降低。治疗48小时后,平均动脉压(p = 0.0005)、肝性脑病分级(p = 0.04)和血清肌酐(p = 0.0002)均有所改善。总体死亡率为45.4%(n = 10)。8名儿童接受了紧急肝移植。5例患者肝功能自发恢复。
高容量血液滤过治疗可显著改善等待紧急肝移植的急性肝衰竭患儿的血流动力学稳定性和神经状态。